Dry Needling Versus Strain-counterstrain on the Upper Trapezius (DNJ)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by Cardenal Herrera University.
Recruitment status was  Not yet recruiting
Information provided by:
Cardenal Herrera University
ClinicalTrials.gov Identifier:
First received: February 4, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted

February 4, 2011
February 4, 2011
February 2011
June 2011   (final data collection date for primary outcome measure)
Pain Pressure Threshold [ Time Frame: 6 sessions ] [ Designated as safety issue: No ]
Amount of pressure (Kg/cm2) applied at the myofascial trigger point site that elicit pain for the patient will be reported. Analogy pressure algometer(Wagner, FDK 20) will be used.
Same as current
No Changes Posted
  • Pain at rest [ Time Frame: 6 sessions ] [ Designated as safety issue: No ]
    Visual Analogue Scale
  • Neck Disability [ Time Frame: 6 sessions ] [ Designated as safety issue: No ]
    Neck Disability Index
  • Electromyographic activity of the upper trapezius [ Time Frame: 6 sessions ] [ Designated as safety issue: No ]
    Surface EMG will be recorded (MP 100 de BIOPAC Systems; Goleta, CA, USA). Electrodes will be located to register activity of the Upper trapezius, according to SENIAM guidelines. Microvolts of activity at rest will be recorded. Data will be normalized through calculation of maximal voluntary contraction, so that final data will be reported as a percentage.
Same as current
Not Provided
Not Provided
Dry Needling Versus Strain-counterstrain on the Upper Trapezius
Dry Needling Versus Strain Counterstrain Technique: Pilot Study Comparing Effects Over the Upper Trapezius Myofascial Trigger Point

This study investigates the effect of two different techniques (dry needling and Strain-counterstrain manual technique) on the upper trapezius myofascial trigger point (MTP). Subjects with active or latent MTP in this location of the muscle will be identified and will be randomly assigned to one out of three groups: dry needling, strain-counterstrain or placebo manual technique. Pain pressure threshold, provoked pain, pain at rest, neck disability and EMG activity of the upper trapezius will be registered before and after six sessions of treatment.

Not Provided
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Treatment
Neck Pain
  • Other: Dry needling
    Deep dry needling until achieving twitch response of the muscle
  • Other: Strain-counterstrain technique
    A manual technique to release tension of painful muscles.
  • Other: Placebo manual technique
    A placebo technique, consisting of manual contact of the therapist with the patient without any further therapeutic approach
  • Experimental: Dry Needling of trigger point
    Deep dry needling will be applied on the upper trapezius myofascial trigger point
    Intervention: Other: Dry needling
  • Experimental: Strain-counterstraing technique
    This manual technique will be applied at the upper trapezius.
    Intervention: Other: Strain-counterstrain technique
  • Placebo Comparator: Placebo manual technique
    A technique simulating strain-counterstrain, but without any therapeutic manoeuvre will be applied at the upper trapezius site.
    Intervention: Other: Placebo manual technique
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Not yet recruiting
July 2011
June 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Active myofascial trigger point at the upper trapezius

Exclusion Criteria:

  • Diagnosed fibromyalgia
  • Cervical radiculopathy
  • Facial neuralgia
  • Coagulation alteration
  • Cancer
  • Allergy (included needles)
  • History of cervical or shoulder surgery
  • History of deep venous thrombosis
  • History of myopathy
  • History of infiltration at upper trapezius trigger point
  • Anticoagulant medication
  • Aspirin intake during the last 3 days
  • Drug intake (AINES, narcotics, antiepileptics, or any other analgesic medication)
  • Pregnancy
18 Years and older
Contact: Eva Segura-Ortí, PhD 961369000 ext 1371 esegura@uch.ceu.es
Eva Segura Ortí, Universidad CEU Cardenal Herrera
Cardenal Herrera University
Not Provided
Principal Investigator: Eva Segura-Ortí, PhD Cardenal Herrera University
Cardenal Herrera University
January 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP